Agilent Technologies launches platform to analyse cell-free DNA

Agilent Technologies has introduced OneSight, a new software platform designed to help researchers visualise and analyse chromosomal aneuploidies in cell-free DNA sequencing data.

The new bioinformatics product was unveiled at the annual meeting of the American College of Medical Genetics and Genomics this week in Tampa, Florida.

Herman Verrelst, Agilent vice president and general manager of the company's Genomics Solutions Division and Clinical Applications Division, said: "With OneSight, researchers will be able to gain a deeper understanding of their sequencing data and apply that to a wide range of applications, from the early detection of cancer to screening for fetal abnormalities."

OneSight offers genetics laboratories a cost-effective way to perform high-quality, cell-free DNA analysis in-house. The new software was developed with expertise from a company Agilent acquired last year, Cartagenia, known for its software solutions for variant assessment and reporting of clinical genomics data.